Combined with the findings from previous studies, this study aimed to explore whether IDH1 mutation in cholangiocarcinoma impairs tumor progression by sensitizing cells to erastin-induced ferroptosis. The gene discussed is IDH1; the disease is cholangiocarcinoma.